Stock Analysis of SLN ( Silence Therapeutics PLC Sponsored ADR )
STOCK RANK
The Stock Rank is a quick snapshot of a stock’s potential, based on key financial ratios in four areas:
Quality, Value, Growth, and Momentum. You can explore detailed insights below for each category.
Stock Rank
QUALITY
ROA-44.97%
ROIC-240.14%
Debt/Equity0.0
Current Ratio9.83
Operating Margin-195.48%
VALUE
Price/Book6.47
Earnings Yield-5.48%
EV/EBITDA-9.63
Price/Sales40.31
Dividend Yield0.0%
GROWTH
Asset 1-Year Growth-7.51%
EPS 1-Year Growth-193.69%
Revenue Average Growth (3-Year)71.86%
Revenue 1-Year Growth46.32%
EBITDA Average Growth (3-Year)-216.71%
MOMENTUM
1-Week Return1.97%
1-Month Return4.52%
3-Month Return-1.8%
6-Month Return-7.09%
12-Month Return128.49%
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
For more details on short-term price trend, check out technical analysis of SLN
Discover additional signals and ratios for Quality, Value, Growth, and
Momentum. To integrate these factors into your own spreadsheets or software, access Signal DB here.
For building multi-factor portfolios, explore our Portfolio Toolbox
.
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.